Abstract: The present invention relates to anti-aging composition comprising indole-3-acetic acid and oleanolic acid. Also disclosed herein are the methods of using such a composition for preventing and reducing the signs of skin aging.
CLIAMS:1.A cosmetic composition for preventing and reducing signs of skin aging comprising:
a)0.000002% to 0.00044% (w/w) of indole 3-acetic acid;
b)0.00005% to 1% (w/w) of oleanolic acid; and
c)70% to 99.9% (w/w) of a cosmetically acceptable carrier.
2.The cosmetic composition as claimed in claim 1, wherein the signs of skin aging are selected from the group consisting of wrinkles, fine lines, sagging skin, lack of radiance, and combinations thereof.
3.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition comprises 0.0001% (w/w) of indole 3-acetic acid.
4.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition comprises 0.0001% (w/w) of oleanolic acid.
5.The cosmetic composition as claimed in claim 1, wherein the cosmetic composition is formulated in a form selected from the group consisting of skin cream, skin lotion, sunscreen lotion, anti-aging product, skin foundation, gel, skin spot correction product, serums, moisturizing spray, facial scrub, and facial peel.
6.A method for preventing and reducing signs of skin aging by topically administering a cosmetic composition, wherein the cosmetic composition comprises:
a)0.000002% to 0.00044% (w/w) of indole 3-acetic acid;
b)0.00005% to 1% (w/w) of oleanolic acid; and
c)70% to 99.9% (w/w) of a cosmetically acceptable carrier.
7.The method as claimed in claim 6, wherein the signs of skin aging are selected from the group consisting of wrinkles, fine lines, sagging skin, lack of radiance, and combinations thereof.
8.The method as claimed in claim 6, wherein the cosmetic composition comprises 0.0001% (w/w) of indole 3-acetic acid.
9.The method as claimed in claim 6, wherein the cosmetic composition comprises 0.0001% (w/w) of oleanolic acid.
,TagSPECI:As Attached
| # | Name | Date |
|---|---|---|
| 1 | 2805-CHE-2013-Correspondence to notify the Controller [08-07-2020(online)].pdf | 2020-07-08 |
| 1 | SPEC.pdf | 2013-06-27 |
| 2 | FORM 5.pdf | 2013-06-27 |
| 2 | 2805-CHE-2013-US(14)-HearingNotice-(HearingDate-09-07-2020).pdf | 2020-06-11 |
| 3 | FORM 3.pdf | 2013-06-27 |
| 3 | 2805-CHE-2013-ABSTRACT [05-07-2019(online)].pdf | 2019-07-05 |
| 4 | FIG.pdf | 2013-06-27 |
| 4 | 2805-CHE-2013-DRAWING [05-07-2019(online)].pdf | 2019-07-05 |
| 5 | 2805-CHE-2013-FER_SER_REPLY [05-07-2019(online)].pdf | 2019-07-05 |
| 5 | 2805-CHE-2013 POWER OF ATTORNEY 23-07-2013.pdf | 2013-07-23 |
| 6 | 2805-CHE-2013-OTHERS [05-07-2019(online)].pdf | 2019-07-05 |
| 6 | 2805-CHE-2013 CORRESPONDENCE OTHERS 23-07-2013.pdf | 2013-07-23 |
| 7 | 2805-CHE-2013-FER.pdf | 2019-01-09 |
| 7 | 2805-CHE-2013 FORM -1 25-07-2013.pdf | 2013-07-25 |
| 8 | Form 18 [12-01-2017(online)].pdf | 2017-01-12 |
| 8 | 2805-CHE-2013 CORRESPONDENCE OTHERS 25-07-2013.pdf | 2013-07-25 |
| 9 | Form 18 [12-01-2017(online)].pdf | 2017-01-12 |
| 9 | 2805-CHE-2013 CORRESPONDENCE OTHERS 25-07-2013.pdf | 2013-07-25 |
| 10 | 2805-CHE-2013 FORM -1 25-07-2013.pdf | 2013-07-25 |
| 10 | 2805-CHE-2013-FER.pdf | 2019-01-09 |
| 11 | 2805-CHE-2013-OTHERS [05-07-2019(online)].pdf | 2019-07-05 |
| 11 | 2805-CHE-2013 CORRESPONDENCE OTHERS 23-07-2013.pdf | 2013-07-23 |
| 12 | 2805-CHE-2013-FER_SER_REPLY [05-07-2019(online)].pdf | 2019-07-05 |
| 12 | 2805-CHE-2013 POWER OF ATTORNEY 23-07-2013.pdf | 2013-07-23 |
| 13 | FIG.pdf | 2013-06-27 |
| 13 | 2805-CHE-2013-DRAWING [05-07-2019(online)].pdf | 2019-07-05 |
| 14 | FORM 3.pdf | 2013-06-27 |
| 14 | 2805-CHE-2013-ABSTRACT [05-07-2019(online)].pdf | 2019-07-05 |
| 15 | FORM 5.pdf | 2013-06-27 |
| 15 | 2805-CHE-2013-US(14)-HearingNotice-(HearingDate-09-07-2020).pdf | 2020-06-11 |
| 16 | SPEC.pdf | 2013-06-27 |
| 16 | 2805-CHE-2013-Correspondence to notify the Controller [08-07-2020(online)].pdf | 2020-07-08 |
| 1 | 2805-CHE-2013Searchstrategy_04-01-2019.pdf |